Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -11541.50% is 32% below its 5-year average of -8760.64%, near the high end of its 5-year range (-44453.33%–-3842.38%).
34.76% above its 12-month average of -17692.15%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5941.11%.
OPERATING MARGIN
-11541.50%
OPERATING MARGIN AVG TTM
-17692.15%
OPERATING MARGIN AVG 3Y
-9468.38%
OPERATING MARGIN AVG 5Y
-8760.64%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+34.76%
CURRENT VS 3Y AVG
-21.90%
CURRENT VS 5Y AVG
-31.74%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Clene Inc.
Market Cap
$49.96M
Operating Margin
-11541.50%
TTM Avg
-17692.15%
3Y Avg
-9468.38%
5Y Avg
-8760.64%
Market Cap
$50.25M
Operating Margin
-9240.66%
TTM Avg
-8899.44%
3Y Avg
-6820.53%
5Y Avg
-4916.43%
Market Cap
$49.50M
Operating Margin
-230.92%
TTM Avg
-150.83%
3Y Avg
-322.13%
5Y Avg
-477.29%
Market Cap
$50.51M
Operating Margin
-111.45%
TTM Avg
-10696.13%
3Y Avg
-10482.04%
5Y Avg
-431164.93%
Market Cap
$51.12M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.58M
Operating Margin
-61738.00%
TTM Avg
-183136.86%
3Y Avg
-98100.06%
5Y Avg
-86611.75%
Market Cap
$52.95M
Operating Margin
N/A
TTM Avg
-19.41%
3Y Avg
-9.70%
5Y Avg
-6.47%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clene Inc. (CLNN) | $49.96M | -11541.50% | -17692.15% | -9468.38% | -8760.64% |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | -9240.66% | -8899.44% | -6820.53% | -4916.43% |
| Celularity Inc. (CELU)vs › | $49.50M | -230.92% | -150.83% | -322.13% | -477.29% |
| Apollomics, Inc. (APLM)vs › | $50.51M | -111.45% | -10696.13% | -10482.04% | -431164.93% |
| biote Corp. (BTMD)vs › | $49.40M | 18.50% | 17.27% | 3.29% | 10.87% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| INmune Bio, Inc. (INMB)vs › | $51.58M | -61738.00% | -183136.86% | -98100.06% | -86611.75% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.95M | N/A | -19.41% | -9.70% | -6.47% |
| ImageneBio Inc (IMA)vs › | $53.01M | -6056.37% | -3556.76% | -2097.71% | -1497.54% |
Gross Margin
78.5%
Operating Margin
-11541.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -5941.11% |
| 2026-03-31 | -13740.00% |
| 2025-12-31 | -9407.79% |
| 2025-09-30 | -37653.33% |
| 2025-06-30 | -21718.52% |
| 2025-03-31 | -5032.10% |
| 2024-12-31 | -9510.99% |
| 2024-09-30 | -8982.76% |
| 2024-06-30 | -8121.98% |
| 2024-03-31 | -12646.58% |
| 2023-12-31 | -5841.18% |
| 2023-09-30 | -8835.19% |
| 2023-06-30 | -3842.38% |
| 2023-03-31 | -10029.91% |
| 2022-12-31 | -4988.46% |
| 2022-09-30 | -5635.06% |
| 2022-06-30 | -38842.86% |
| 2022-03-31 | -44453.33% |
| 2021-12-31 | -7064.32% |
| 2021-09-30 | -9500.00% |
| 2021-06-30 | -6853.23% |
| 2021-03-31 | -5490.61% |
| 2020-12-31 | -20551.72% |
| 2020-09-30 | -5807.14% |
| 2020-06-30 | -50677.78% |
| 2020-03-31 | -5717.14% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
